Type 2 Diabetes Mellitus
Conditions
Interventions
The intervention is a six-month multidisciplinary care model for patients with type 2 diabetes, consisting of monthly structured activities. In month 1, participants undergo baseline health assessment
Experimental Behavioral,No Intervention No treatment
Multidisciplinary Care Model for Type 2 Diabetes,Usual care
Sponsors
Phibunmangsahan Hospital, Ubon Ratchathani Province, Ministry of Public Health, Thailand
The Nurse Alumni Association of the Ministry of Public Health.
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Voluntarily agrees and provides informed consent to participate with willingness to modify lifestyle behaviors 2.Diagnosed with type 2 diabetes mellitus within the past 5 years 3.Age 30 to 70 years This range clearly differentiates type 1 and type 2 diabetes ensures ability to modify health behaviors and reduces the risk of severe comorbidities in older adults 4.No cognitive impairment in participants aged 60 years or older assessed by the Mini Cog Test score greater or equal to 3 5.Not using insulin injection for glycemic control 6.No comorbidities that interfere with intensive dietary management such as severe or unstable heart failure or recent diagnosis of ischemic heart disease within the past 6 months 7.Estimated glomerular filtration rate eGFR greater than 45 mL per min per 1 point 73 m2
Exclusion criteria
Exclusion criteria: 1.Patients with severe diabetes complications such as end stage renal disease requiring dialysis or severe heart failure 2.Patients diagnosed with psychiatric disorders that affect decision making ability or with intellectual or cognitive impairment that may interfere with study participation 3.Pregnant women or breastfeeding mothers due to physiological and hormonal changes that may affect study outcomes 4.Patients with time constraints or responsibilities that prevent participation in training follow up or assessments throughout the 6 month study period 5.Patients currently enrolled in other health intervention research projects that may interfere with or affect the validity of study results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diabetes remission Month 6 Defined according to ADA consensus criteria, assessed from HbA1c laboratory results and medical records at 6 months.,HbA1c Baseline (Month 0), Month 3, Month 6 Measured by standardized hospital laboratory tests at months 3 and 6; outcome defined as clinically significant reduction in HbA1c. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar (mg/dL) Baseline(Month 0), Month 3, Month 6 Assessed by hospital laboratory testing,Lipid Profile (mg/dL: Total cholesterol, Triglycerides, LDL, HDL ) Baseline(Month 0), Month 3, Month 6 Assessed by hospital laboratory testing ,Body Mass Index Baseline(Month 0), Month 3, Month 6 Calculated from weight and height measured with calibrated equipment,Waist Circumference Baseline(Month 0), Month 3, Month 6 aist circumference is measured using a standard measuring tape at the level of the umbilicus, ensuring the tape is parallel to the floor and not applied too tightly or loosely.,Self-care behavior Month 0, Month 6 Measured by validated self-care behavior questionnaire,Diabetes knowledge Month 0, Month 6 Measured by validated diabetes knowledge questionnaire | — |
Countries
Thailand
Contacts
Public ContactMr.Kittisak Promdaw
Phibunmangsahan Hospital, Ubon Ratchathani, Thailand
Outcome results
None listed